What Is CIDP and How does Vyvgart Hytrulo Work to Treat It? The exact cause of CIDP is not known, but it is thought to be an autoimmune disease in which the immune system mistakenly damages your ...

Common causes of neuropathy such as diabetes ... used in conjunction with the other studies and the clinical presentation to suggest a diagnosis of CIDP. Once the diagnosis is secured, treatment with ...

If approved, Vyvgart Hytrulo (efgartigimod alfa) will be the first drug in the FcRn blocker class to treat CIDP, a rare autoimmune disease of the peripheral nervous system that causes fatigue ...

He noted the significant early impact on CIDP and progress in clinical milestones, including advancing empasiprubart and efgartigimod into Phase III programs. Van Hauwermeiren announced that 2025 will ...